BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1484084)

  • 1. Determination of a new calcium antagonist and its main metabolite in plasma by thermospray liquid chromatography-mass spectrometry.
    Hatada K; Kimura M; Ono I; Ozaki M
    J Chromatogr; 1992 Nov; 583(1):116-21. PubMed ID: 1484084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-tandem mass spectrometric assay for the light sensitive calcium channel antagonist lacidipine in human plasma.
    Karra VK; Pilli NR; Polagani SR; Inamadugu JK; Seshagiri Rao JV
    J Pharm Biomed Anal; 2012 Jul; 66():211-7. PubMed ID: 22459503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatographic-negative-ion chemical ionization mass spectrometric determination of a new dihydropyridine calcium antagonist (MPC-1304) and its metabolites in human plasma and urine.
    Umeno Y; Matsushima E; Maniwa M; Marunaka T
    J Chromatogr; 1988 Dec; 434(1):123-33. PubMed ID: 3243807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of a new dihydropyridine calcium antagonist (MPC-1304) and its metabolite in dog plasma by high-performance liquid chromatography with electrochemical detection.
    Iida Y; Kinouchi Y; Takeichi Y; Imai T; Otagiri M
    J Chromatogr; 1991 Nov; 571(1-2):277-82. PubMed ID: 1810957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of benidipine hydrochloride in human plasma by capillary column gas chromatography-negative ion chemical ionization mass spectrometry.
    Magara H; Kobayashi H; Kobayashi S
    J Chromatogr; 1993 Jul; 617(1):59-63. PubMed ID: 8376538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of benidipine in human plasma using liquid chromatography-tandem mass spectrometry.
    Kang W; Yun HY; Liu KH; Kwon KI; Shin JG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):311-4. PubMed ID: 15135106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of aranidipine and its active metabolite in human plasma by liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Tian L; Jiang J; Huang Y; Xu L; Liu H; Li Y
    Rapid Commun Mass Spectrom; 2006; 20(19):2871-7. PubMed ID: 16941544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the dihydropyridine aryloxypropanolamine Z6568 and its acidic metabolites in plasma, urine and tissues by solid phase extraction and liquid chromatography/negative-ion mass spectrometry.
    Gregori M; Castelnovo P
    J Mass Spectrom; 1996 Sep; 31(9):994-1002. PubMed ID: 8831152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple, sensitive and rapid liquid chromatographic/electrospray ionization tandem mass spectrometric method for the quantification of lacidipine in human plasma.
    Ramakrishna NV; Vishwottam KN; Puran S; Manoj S; Santosh M; Koteshwara M
    J Mass Spectrom; 2004 Jul; 39(7):824-32. PubMed ID: 15282762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study.
    Tang J; Zhu R; Zhao R; Cheng G; Peng W
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):923-8. PubMed ID: 18534803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectrometric detection.
    Zhang X; Zhai S; Zhao R; Ouyang J; Li X; Baeyens WR
    Anal Chim Acta; 2007 Sep; 600(1-2):142-6. PubMed ID: 17903476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of the calcium channel antagonists amlodipine, lercanidipine, nitrendipine, felodipine, and lacidipine in human plasma using liquid chromatography-tandem mass spectrometry.
    Baranda AB; Mueller CA; Alonso RM; Jiménez RM; Weinmann W
    Ther Drug Monit; 2005 Feb; 27(1):44-52. PubMed ID: 15665746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective determination of azelnidipine in human plasma using liquid chromatography-tandem mass spectrometry.
    Kawabata K; Samata N; Urasaki Y; Fukazawa I; Uchida N; Uchida E; Yasuhara H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):389-97. PubMed ID: 17350354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective and rapid liquid chromatography-mass spectrometry method for the determination of lercanidipine in human plasma.
    Salem II; Idrees J; Al Tamimi JI; Farina P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):201-7. PubMed ID: 15063326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of (+)- and (-)-nilvadipine in human plasma using chiral stationary-phase liquid chromatography and gas chromatography-mass spectrometry, and a preliminary pharmacokinetic study in humans.
    Tokuma Y; Fujiwara T; Noguchi H
    J Pharm Sci; 1987 Apr; 76(4):310-3. PubMed ID: 3598890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a carrier for quantitation of a new dihydropyridine calcium antagonist (OPC-13340) in human plasma by highly sensitive gas chromatography with negative-ion chemical ionization mass spectrometry.
    Nagasawa M; Sasabe H; Shimizu T; Mori H
    J Chromatogr; 1992 Jun; 577(2):275-81. PubMed ID: 1400758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of azelnidipine and two metabolites in human plasma using liquid chromatography-tandem mass spectrometry.
    Kawabata K; Urasaki Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 844(1):45-52. PubMed ID: 16854634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the dihydropyridine aryloxypropanolamine compound Z6568 and four metabolites in plasma by liquid chromatography/negative-ion mass spectrometry.
    Castelnovo P; Gregori M
    J Mass Spectrom; 1996 Jan; 31(1):37-46. PubMed ID: 8799260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective determination of lercanidipine in human plasma for pharmacokinetic studies by normal-phase liquid chromatography-tandem mass spectrometry.
    Jabor VA; Coelho EB; Ifa DR; Bonato PS; dos Santos NA; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):429-37. PubMed ID: 14581082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radio high-performance liquid chromatographic determination of 14C-labelled LF 2-0254, A 1,4-dihydropyridine calcium antagonist, in rat and dog plasma using off-line liquid scintillation counting.
    Baillet G; Pourcelot A; Weil A; Prevost C; Guichard JP
    J Chromatogr; 1988 Dec; 456(1):183-90. PubMed ID: 3243866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.